Vision
Mission
Vision
Build a leading immunotherapy platform to cure solid tumors and autoimmune diseases.
Mission
Develop innovative, scalable, next-generation nanobody T-cell engager therapies for solid tumors and autoimmune diseases.
Curing cancer. Restoring lives. One breakthrough at a time.
About Sidocel
- Advancing Life-Saving Nanobody Therapies
- Developing scalable, first-in-class tri-specific nanobody T-cell engagers and in vivo nanobody-based CAR-T therapies
- Breakthrough Trident platforms driving next-generation cancer and autoimmune treatments
With Sidocel's innovative, next-generation immunotherapies, we’re redefining efficacy and safety through more targeted, effective, and safer interventions.
TRIDENT Platform
In Vivo Nanobody TCE Armored CAR-T
TRIDENTTM (TRI-Specific Destructive-Enhanced Nanobody T-Cell Engager)
